BRAF and melanoma: The results of the present work extend previous observations about a pro-oncogenic role of GALC in Braf wildtype murine melanoma cells [1] by demonstrating that GALC overexpression increases the tumorigenic potential of human melanoma cells harboring the tumor-driving BRAF(V600E) mutation.